Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |